TY - JOUR
T1 - Large language models in clinical trials
T2 - applications, technical advances, and future directions
AU - Lin, Anqi
AU - Wang, Zhihan
AU - Jiang, Aimin
AU - Chen, Li
AU - Qi, Chang
AU - Zhu, Lingxuan
AU - Mou, Weiming
AU - Gan, Wenyi
AU - Zeng, Dongqiang
AU - Xiao, Mingjia
AU - Chu, Guangdi
AU - Peng, Shengkun
AU - Wong, Hank Z.H.
AU - Zhang, Lin
AU - Zhang, Hengguo
AU - Deng, Xinpei
AU - Wang, Yaxuan
AU - Zhang, Jian
AU - Cheng, Quan
AU - Tang, Bufu
AU - Luo, Peng
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/12
Y1 - 2025/12
N2 - Background: As clinical trials scale up and grow more complex, researchers are facing mounting challenges, including inefficient participant recruitment, complex data management, and limited risk monitoring. These issues not only increase the workload for clinical researchers but also compromise trial reliability and safety, potentially elevating the risk of trial failure. Large language models (LLMs), as an emerging technology in natural language processing (NLP), exhibit notable advantages across various tasks, such as information extraction and relation classification. Main text: With domain-specific pre-training and fine-tuning, LLMs present promising potential in clinical trial tasks such as automated patient-trial matching and the extraction and processing of trial data, which are anticipated to reduce time and financial costs. Additionally, they offer valuable insights for scientific rationale, medical decision-making, and trial endpoint prediction. In this context, an increasing number of studies have begun to explore the applications of LLMs in the design and conduct of clinical trials. Conclusion: This paper provides a review of LLM applications in clinical trials with an emphasis on real-world integration. Comparative advantages over traditional NLP models, technical limitations, and future implementation challenges are also discussed. This narrative review aims to highlight the potential of LLMs in clinical trial workflows and clarify key challenges and future directions.
AB - Background: As clinical trials scale up and grow more complex, researchers are facing mounting challenges, including inefficient participant recruitment, complex data management, and limited risk monitoring. These issues not only increase the workload for clinical researchers but also compromise trial reliability and safety, potentially elevating the risk of trial failure. Large language models (LLMs), as an emerging technology in natural language processing (NLP), exhibit notable advantages across various tasks, such as information extraction and relation classification. Main text: With domain-specific pre-training and fine-tuning, LLMs present promising potential in clinical trial tasks such as automated patient-trial matching and the extraction and processing of trial data, which are anticipated to reduce time and financial costs. Additionally, they offer valuable insights for scientific rationale, medical decision-making, and trial endpoint prediction. In this context, an increasing number of studies have begun to explore the applications of LLMs in the design and conduct of clinical trials. Conclusion: This paper provides a review of LLM applications in clinical trials with an emphasis on real-world integration. Comparative advantages over traditional NLP models, technical limitations, and future implementation challenges are also discussed. This narrative review aims to highlight the potential of LLMs in clinical trial workflows and clarify key challenges and future directions.
KW - Clinical data management
KW - Clinical trials
KW - Large language models
KW - LLMs
KW - Natural language processing
UR - https://www.scopus.com/pages/publications/105018648688
U2 - 10.1186/s12916-025-04348-9
DO - 10.1186/s12916-025-04348-9
M3 - Review Article
C2 - 41088200
AN - SCOPUS:105018648688
SN - 1741-7015
VL - 23
JO - BMC Medicine
JF - BMC Medicine
IS - 1
M1 - 563
ER -